Significance of Histopathological Evaluation in Primary Therapy for Breast Cancer - Recent Trends in Primary Modality with Pathological Complete Response (pCR) as Endpoint
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-04-10
著者
-
Kurosumi Masafumi
Department Of Pathology Saitama Cancer Center
-
Kurosumi Masafumi
Department Of Anatomy Osaka University Medical School
関連論文
- Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
- Issues in the Assessment of the Pathologic Effect of Primary Systemic Therapy for Breast Cancer
- Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Recurrence after Sentinel Lymph Node Biopsy With or Without Axillary Lymph Node Dissection in Patients with Breast Cancer
- Combination Docetaxel and Trastuzumab Treatment for Patients with HER-2-Overexpressing Metastatic Breast Cancer : A Multicenter, Phase-II Study
- Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
- Angiogenesis Inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470) Inhibits Tumor Angiogenesis, Growth and Spontaneous Metastasis of MKL-4 Human Breast Cancer Cells in Female Athymic Nude Mice
- Current Trends of Sentinel Lymph Node Biopsy for Breast Cancer : A Surgeon's Perspective
- Added Value of the Presence of Blue Nodes or Hot Nodes in Sentinel Lymph Node Biopsy of Breast Cancer